Deep Genomics Inc
Deep Genomics Inc., based in Toronto, Ontario, is at the forefront of revolutionizing drug development through artificial intelligence and RNA biology. The company aims to create programmable RNA therapies that target genetic conditions, leveraging its proprietary AI platform to navigate the complexities of RNA data and identify novel therapeutic candidates.
Since its inception, Deep Genomics has made significant strides, including the release of its first Foundation Model for RNA biology, Big RNA, which expands its capabilities to address complex genetic diseases. The company is committed to developing innovative solutions for any gene and any genetic condition, positioning itself as a leader in the field of genetic medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.

